Anti-androgen receptor activity of apoptotic CK2 inhibitor CX4945 in human prostate cancer LNCap cells

CX4945, a potent and selective small molecule inhibitor of CK2, exhibits its anti-cancer activity in LNCap cells via the independent inhibitions of AR and Akt-survivin signalings.